Would you like to know if you’ve had COVID-19?
The BioDiagnostics BioCard™ was developed in direct response to the COVID-19 pandemic, with research beginning in February 2020 in the UK. The BioCard™ utilises the company’s 40 years’ experience in antibody testing and its extensive in vitro diagnostics expertise. The BioCard™ is CE marked and available for delivery throughout the UK and Europe immediately, and the USA imminently.
Physical adaptations from the established QuickCard™ technology, combined with specific changes to the Biochemistry of the device, have resulted in a robust, accurate and ultra-rapid IgG antibody test indicative of a COVID-19 specific immune response.
A positive result demonstrates the presence of specific antibodies to protect against COVID-19, almost certainly inferring past infection.
BUY NOW
Natures Vaccine?
These specific antibodies are the same ones it is anticipated will be elicited by vaccines currently in development, which aim which provide immunity to COVID-19 infections. If you have a positive result, it very strongly suggests your body has already made them, naturally.